Literature DB >> 1707299

Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mouse mammary epithelium.

G H Smith1, T Mehrel, D R Roop.   

Abstract

Two keratins whose expression has been associated with proliferation (K14) and hyperproliferation (K6) in mouse epithelia were detected in normal, preneoplastic, and neoplastic mouse mammary tissues. K6 and K14 keratins were independently expressed in distinct epithelial cell populations in developing mammary anlage. K6 was confined to a small number of mammary epithelial cells associated with the growing end buds and among the proximal luminal epithelium, whereas K14 expression appeared in basally located fusiform cells that correspond to the location of mammary myoepithelial cells. This pattern was maintained in mature glands and through full functional differentiation with the exception that K6-positive cells were only rarely detectable. During lobuloalveolar growth in early pregnancy, K6 and K6/K14 coexpressing cells were observed among the luminal and suprabasal cells in the expanding lobular epithelium. This K6/K14 coexpressing epithelial subset persisted throughout pregnancy, lactation, and involution, albeit in much smaller numbers than observed in early pregnancy. Two patterns of K6 and K14 expression in preneoplastic and neoplastic lesions of mouse mammary glands were induced by various carcinogenic stimuli. In one, increased numbers of K6- or K14-positive cells were present in distinct cellular populations; in the other, coexpression of K6/K14 was found in a large subpopulation of both preneoplastic and neoplastic mammary epithelium. These observations suggest that expression of K6 and K14 keratins in the mouse mammary gland is associated with growth and expansion of specific mammary epithelial cell populations, and as such these keratins may be useful probes with which to identify mammary epithelium-specific primordial cells. In agreement with this possibility, K6/K14 expression was demonstrated within a distinct subset of morphologically distinct luminal mammary epithelial cells that have been reported to possess kinetic properties in vitro consistent with those expected of latent mammogenic stem cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1707299

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  45 in total

1.  Immortalization of mammary cells from estrogen receptor alpha knock-out and wild-type mice.

Authors:  S O Mueller; H Tahara; J C Barrett; K S Korach
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Nov-Dec       Impact factor: 2.416

2.  Reprogramming human cancer cells in the mouse mammary gland.

Authors:  Karen M Bussard; Corinne A Boulanger; Brian W Booth; Robert D Bruno; Gilbert H Smith
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

Review 3.  The emerging picture of the mouse mammary stem cell.

Authors:  François Vaillant; Marie-Liesse Asselin-Labat; Mark Shackleton; Geoffrey J Lindeman; Jane E Visvader
Journal:  Stem Cell Rev       Date:  2007-06       Impact factor: 5.739

4.  Netrin-1 can affect morphogenesis and differentiation of the mouse mammary gland.

Authors:  Luigi Strizzi; Mario Mancino; Caterina Bianco; Ahmed Raafat; Monica Gonzales; Brian W Booth; Kazuhide Watanabe; Tadahiro Nagaoka; David L Mack; Beatrice Howard; Robert Callahan; Gilbert H Smith; David S Salomon
Journal:  J Cell Physiol       Date:  2008-09       Impact factor: 6.384

Review 5.  Histochemistry and cell biology: the annual review 2010.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2011-01-29       Impact factor: 4.304

Review 6.  Hedgehog signalling in breast cancer.

Authors:  Maria Kasper; Viljar Jaks; Marie Fiaschi; Rune Toftgård
Journal:  Carcinogenesis       Date:  2009-02-23       Impact factor: 4.944

7.  Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model.

Authors:  Binwu Tang; Naomi Yoo; Mary Vu; Mizuko Mamura; Jeong-Seok Nam; Akira Ooshima; Zhijun Du; Pierre-Yves Desprez; Miriam R Anver; Aleksandra M Michalowska; Joanna Shih; W Tony Parks; Lalage M Wakefield
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

8.  Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.

Authors:  Yi Li; Bryan Welm; Katrina Podsypanina; Shixia Huang; Mario Chamorro; Xiaomei Zhang; Tracey Rowlands; Mikala Egeblad; Pam Cowin; Zena Werb; Lee K Tan; Jeffrey M Rosen; Harold E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

9.  Cytokeratin expression during mouse embryonic and early postnatal mammary gland development.

Authors:  Peng Sun; Yuanyang Yuan; Aihua Li; Boan Li; Xing Dai
Journal:  Histochem Cell Biol       Date:  2009-11-25       Impact factor: 4.304

10.  Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation.

Authors:  Bingnan Gu; Peng Sun; Yuanyang Yuan; Ricardo C Moraes; Aihua Li; Andy Teng; Anshu Agrawal; Catherine Rhéaume; Virginia Bilanchone; Jacqueline M Veltmaat; Ken-Ichi Takemaru; Sarah Millar; Eva Y-H P Lee; Michael T Lewis; Boan Li; Xing Dai
Journal:  J Cell Biol       Date:  2009-06-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.